These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16563524)

  • 21. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.
    Honda M; Arai T; Fukazawa M; Honda Y; Tsuchiya K; Salehi A; Akiyama H; Mignot E
    Neurology; 2009 Aug; 73(7):511-7. PubMed ID: 19687452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain.
    Kornum BR; Faraco J; Mignot E
    Curr Opin Neurobiol; 2011 Dec; 21(6):897-903. PubMed ID: 21963829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice.
    Katzav A; Arango MT; Kivity S; Tanaka S; Givaty G; Agmon-Levin N; Honda M; Anaya JM; Chapman J; Shoenfeld Y
    J Autoimmun; 2013 Sep; 45():24-30. PubMed ID: 23834844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.
    Martínez-Rodríguez JE; Sabater L; Graus F; Iranzo A; Santamaria J
    Sleep; 2007 Jan; 30(1):27-8. PubMed ID: 17310861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid and preferential activation of Fos protein in hypocretin/orexin neurons following the reversal of dehydration-anorexia.
    Watts AG; Sanchez-Watts G
    J Comp Neurol; 2007 Jun; 502(5):768-82. PubMed ID: 17436292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypocretin/orexin disturbances in neurological disorders.
    Fronczek R; Baumann CR; Lammers GJ; Bassetti CL; Overeem S
    Sleep Med Rev; 2009 Feb; 13(1):9-22. PubMed ID: 18819824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative expression of p2x receptors and ecto-nucleoside triphosphate diphosphohydrolase 3 in hypocretin and sensory neurons in zebrafish.
    Appelbaum L; Skariah G; Mourrain P; Mignot E
    Brain Res; 2007 Oct; 1174():66-75. PubMed ID: 17868657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased immune complexes of hypocretin autoantibodies in narcolepsy.
    Deloumeau A; Bayard S; Coquerel Q; Déchelotte P; Bole-Feysot C; Carlander B; Cochen De Cock V; Fetissov SO; Dauvilliers Y
    PLoS One; 2010 Oct; 5(10):e13320. PubMed ID: 20967199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival rates through time of hypocretin grafted neurons within their projection site.
    Arias-Carrión O; Drucker-Colín R; Murillo-Rodríguez E
    Neurosci Lett; 2006 Aug; 404(1-2):93-7. PubMed ID: 16762505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypocretins, peptides associated with narcolepsy].
    Murillo-Rodríguez E; Arias-Carrión O
    Gac Med Mex; 2007; 143(5):421-5. PubMed ID: 18246936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
    Ohno K; Sakurai T
    Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
    Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
    Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
    Terao A; Haruyama T; Kimura K
    Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.
    Thannickal TC; Siegel JM; Nienhuis R; Moore RY
    Brain Pathol; 2003 Jul; 13(3):340-51. PubMed ID: 12946023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.
    Tonon C; Franceschini C; Testa C; Manners DN; Poli F; Mostacci B; Mignot E; Montagna P; Barbiroli B; Lodi R; Plazzi G
    Brain Res Bull; 2009 Sep; 80(3):147-50. PubMed ID: 19463917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.